Not finding it? Sign in to also search OpenAlex live.
-
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T-cells2022 The Journal of Immunology conference-abstract Immunology and Microbiology T-cell and B-cell Immunology
Carmen Maria Anadon Galindo, Xiaoqing Yu, Kay Hänggi, Subir Biswas, Ricardo A. Chaurio, Gunjan Mandal, +17 more
0citations -
21P: Primary analysis of safety, efficacy and immunogenicity of the therapeutic cancer vaccine PDC*lung01 with or without pembrolizumab in NSCLC: A multicenter phase I/II study2025 Journal of Thoracic Oncology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
J.F. Vansteenkiste, I. Demedts, K. Cuppens, Elvire Pons Tostivint, E. Wauters, Frank Johannes Borm, +13 more
0citations -
Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides2023 Cancer Immunology Immunotherapy article Immunology and Microbiology Immunotherapy and Immune Responses Open access
Toon Stegmann, Anna‐Sophia Wiekmeijer, Kitty M.C. Kwappenberg, Suzanne van Duikeren, Farien Bhoelan, Denzel Bemelman, +4 more
10citations -
Phase I trial to determine safety and immunogenicity of amplivant, a synthetic toll-like receptor 2 ligand, conjugated to two HPV16 E6 synthetic long peptides.2021 Journal of Clinical Oncology conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses
Frank M. Speetjens, Marij J.P. Welters, Marije Slingerland, Peggy de Vos van Steenwijk, Inge C.F.M. Roozen, Sanne Boekestijn, +9 more
3citations -
Oncolytic virotherapy: Sparking durable anti-tumor immunity through microenvironment modulation2025 Seminars in Immunology article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access
Christoph F. Kollmann, Nadine van Montfoort, Pierre Cordelier, Jonathan G. Pol, David P. Olagnier
7citations -
Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions2022 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immunotherapy and Immune Responses Open access
Frank M. Speetjens, Marij J.P. Welters, Marije Slingerland, Mariëtte I.E. van Poelgeest, Peggy J. de Vos van Steenwijk, Inge C.F.M. Roozen, +13 more
39citations -
Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation2023 Journal of Controlled Release article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents
Zili Gu, Timo Schomann, FERRY A. OSSENDORP, Peter ten Dijke, Luis Javier Cruz
86citations -
The role of pigmentation in tumor treatment with the investigational virus-like drug conjugate belzupacap sarotalocan in an in vitro and in vivo murine model2024 Photodiagnosis and Photodynamic Therapy article Medicine Photodynamic Therapy Research Studies Open access
Sen Ma, Ruben V. Huis In't Veld, Cadmus Collins Rich, FERRY A. OSSENDORP, Martine Johanna Jager
0citations -
Abstract 4160: Promoting immunogenicity of synthetic long peptide vaccines based on in vivo IgG complex formation: Preclinical evaluation and clinical entry of the TET platform2022 Cancer Research conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses
Erika A.K. Fletcher, Iliana Kyriaki Kerzeli, Robert A. Cordfunke, Aikaterini Nasi, Gunilla Törnqvist, Rob R.P.M. Valentijn, +18 more
1citations -
343 Identification of tumor-reactive T cells targeting melanoma Dark Antigens™ validates this novel class of targets for development of immunotherapies2022 Regular and Young Investigator Award Abstracts conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents
Tom Hofland, Thomas Morgan Hulen, Elizabeth Verdegaal, Joseph D. Dukes, Shawez Khan, Pita de Kok, +9 more
1citations -
Therapeutic liposomal combination to enhance chemotherapy response and immune activation of tumor microenvironment2024 Journal of Controlled Release article Materials Science Nanoparticle-Based Drug Delivery Open access
Zili Gu, Jie Yin, Candido G. Da Silva, Qi Liu, Luis Javier Cruz, FERRY A. OSSENDORP, +1 more
14citations -
Vaccination with cationic liposome-encapsulated CD4 and CD8 T cell neoepitopes induces superior tumor control2026 Materials Today Bio article Immunology and Microbiology Immunotherapy and Immune Responses Open access
Felicia S. Spitzer, Jeroen Heuts, Brett J. Hos, Stefan G. Romeijn, Marcel G M Camps, FERRY A. OSSENDORP, +1 more
0citations -
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution2020 Nature Communications article Medicine Genetic factors in colorectal cancer Open access cited by 1 patent
Alexej Ballhausen, Moritz Jakob Przybilla, Michael Adrian Jendrusch, Saskia Haupt, Elisabeth Pfaffendorf, Florian Seidler, +24 more
138citations -
Abstract 1802: Personalization of oncolytic virus therapy: Heterogenous anti-tumor responses in preclinical prostate and bladder cancer models2023 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research
Thijs J. Janssen, Geertje van der Horst, Arjanneke F. van de Merbel, Maaike H. van der Mark, Martine L.M. Lamfers, Bernadette G. van den Hoogen, +8 more
0citations